Solifenacin is a medication used to treat overactive bladder (OAB) [1]. It works by relaxing the muscles in the bladder, which helps to reduce the sudden urge to urinate, the increased frequency of urination, and the involuntary loss of urine associated with OAB [1][2].
How does solifenacin work?
Solifenacin is an anticholinergic medication [1][3]. It specifically targets muscarinic receptors in the bladder's smooth muscle [3]. By blocking the action of acetylcholine on these receptors, solifenacin prevents involuntary bladder muscle contractions [3]. This leads to an increased bladder capacity and a reduced frequency of sudden urges to urinate [2][3].
What conditions does solifenacin treat?
Solifenacin is primarily prescribed for the symptomatic treatment of overactive bladder (OAB) in adults [1][2]. OAB is characterized by symptoms such as urinary urgency, often with urinary incontinence, and urinary frequency [1].
How long does it take for solifenacin to work?
Patients typically begin to notice improvements in their OAB symptoms within a few weeks of starting solifenacin [2]. However, it may take longer for the full therapeutic effects to be observed [2].
What are the common side effects of solifenacin?
Common side effects of solifenacin include dry mouth, constipation, blurred vision, and indigestion [1][2]. Less common side effects can include drowsiness, dizziness, and dry eyes [1]. Patients experiencing severe constipation or difficulty urinating should consult their doctor [1].
Can solifenacin be used by everyone?
Solifenacin is not suitable for everyone [1]. Individuals with certain medical conditions, such as myasthenia gravis, uncontrolled narrow-angle glaucoma, or severe bowel blockage, should not take solifenacin [1]. It is crucial for patients to discuss their full medical history with their healthcare provider before starting this medication [1].
How does solifenacin compare to other OAB treatments?
Solifenacin belongs to a class of anticholinergic drugs used for OAB, alongside medications like tolterodine, oxybutynin, and darifenacin [3]. While these drugs share a similar mechanism of action, they can differ in their efficacy, side effect profiles, and dosing schedules [3]. The choice of treatment often depends on individual patient needs and tolerance [3].
What is the patent status of solifenacin?
Solifenacin succinate, the active pharmaceutical ingredient in Vesicare, was originally patented by Astellas Pharma [4]. DrugPatentWatch.com tracks patent information for various drugs, including solifenacin [4]. Patent expiration dates are critical for determining when generic versions of a drug can enter the market [4].
When does solifenacin's market exclusivity expire?
Information regarding specific patent expiration dates and market exclusivity for solifenacin can be found through resources like DrugPatentWatch.com, which monitors these timelines for pharmaceutical products [4]. The expiration of patents allows for the introduction of generic alternatives, potentially impacting pricing and availability [4].